| Peter J Neidenbach, MD | |
|
52 Hospital Dr Ste 3a, Columbus, NC 28722-8516 | |
| (828) 894-2473 | |
| (828) 894-2390 |
| Full Name | Peter J Neidenbach |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 33 Years |
| Location | 52 Hospital Dr Ste 3a, Columbus, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316905631 | NPI | - | NPPES |
| 2214227A | Other | NC | PTAN |
| 9501356 | Other | NC | STATE LICENSE |
| MMD16384MD | Other | SC | STATE LICENCE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | MMD16384MD (South Carolina) | Secondary |
| 207N00000X | Dermatology | 9501356 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Lukes Hospital | Columbus, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical And Surgical Dermatology, Llc | 8527969039 | 3 |
| Medical And Surgical Dermatology, Llc | 8527969039 | 3 |
News Archive
On Friday, July 16, U.S. Department of Health and Human Services Secretary Kathleen Sebelius and U.S. Attorney General Eric Holder will kick off the first in a series of day-long summits bringing together a wide array of federal, state, and local partners, beneficiaries, providers, and other interested parties to discuss innovative ways to eliminate fraud within the U.S. health care system. The summit will include educational panels featuring law enforcement officials, consumer experts, providers, and key government agencies.
An international team of researchers led by Columbia University Medical Center's Herbert Irving Comprehensive Cancer Center and Sweden's Lund University has, for the first time, revealed how mutations in the BRCA1 gene lead to breast cancer.
Numerous studies have shown that monitoring physical activity promotes better health – from reducing body mass index to watching for signs of hypertension, for example. A new study suggests step counters could play yet another role: predicting outcomes for people undergoing chemoradiation therapy for lung cancer.
EKF Diagnostics, the global in vitro diagnostics business, announces the worldwide launch of the new STAT-Site M ß-HB, following successful CE marking.
› Verified 5 days ago
| Entity Name | Medical & Surgical Dermatology, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619194404 PECOS PAC ID: 8527969039 Enrollment ID: O20040117000064 |
News Archive
On Friday, July 16, U.S. Department of Health and Human Services Secretary Kathleen Sebelius and U.S. Attorney General Eric Holder will kick off the first in a series of day-long summits bringing together a wide array of federal, state, and local partners, beneficiaries, providers, and other interested parties to discuss innovative ways to eliminate fraud within the U.S. health care system. The summit will include educational panels featuring law enforcement officials, consumer experts, providers, and key government agencies.
An international team of researchers led by Columbia University Medical Center's Herbert Irving Comprehensive Cancer Center and Sweden's Lund University has, for the first time, revealed how mutations in the BRCA1 gene lead to breast cancer.
Numerous studies have shown that monitoring physical activity promotes better health – from reducing body mass index to watching for signs of hypertension, for example. A new study suggests step counters could play yet another role: predicting outcomes for people undergoing chemoradiation therapy for lung cancer.
EKF Diagnostics, the global in vitro diagnostics business, announces the worldwide launch of the new STAT-Site M ß-HB, following successful CE marking.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter J Neidenbach, MD 52 Hospital Dr Ste 3a, Columbus, NC 28722-8516 Ph: (828) 894-2473 | Peter J Neidenbach, MD 52 Hospital Dr Ste 3a, Columbus, NC 28722-8516 Ph: (828) 894-2473 |
News Archive
On Friday, July 16, U.S. Department of Health and Human Services Secretary Kathleen Sebelius and U.S. Attorney General Eric Holder will kick off the first in a series of day-long summits bringing together a wide array of federal, state, and local partners, beneficiaries, providers, and other interested parties to discuss innovative ways to eliminate fraud within the U.S. health care system. The summit will include educational panels featuring law enforcement officials, consumer experts, providers, and key government agencies.
An international team of researchers led by Columbia University Medical Center's Herbert Irving Comprehensive Cancer Center and Sweden's Lund University has, for the first time, revealed how mutations in the BRCA1 gene lead to breast cancer.
Numerous studies have shown that monitoring physical activity promotes better health – from reducing body mass index to watching for signs of hypertension, for example. A new study suggests step counters could play yet another role: predicting outcomes for people undergoing chemoradiation therapy for lung cancer.
EKF Diagnostics, the global in vitro diagnostics business, announces the worldwide launch of the new STAT-Site M ß-HB, following successful CE marking.
› Verified 5 days ago